Ocugen: Chardan Capital Raises PT to $7, Maintains Buy Rating.

Tuesday, Jan 20, 2026 7:33 am ET1min read
OCGN--

Ocugen: Chardan Capital Raises PT to $7, Maintains Buy Rating.

Ocugen: Chardan Capital Raises PT to $7, Maintains Buy Rating.

Stay ahead of the market.

Get curated U.S. market news, insights and key dates delivered to your inbox.

Comments



Add a public comment...
No comments

No comments yet